Enlitic, Marubeni Sign Agreement for Enlitic Curie Platform Distribution in Japan

Clairvo Technologies, a Marubeni company, will go to market with the Enlitic Curie platform including Curie|ENDEX, Curie|ENCOG and Enlitic’s CXR Focal Opacity component in the Japanese radiology space. The agreement with Enlitic, Inc. will provide applications needed to resolve workflow challenges faced by radiologists and secure Protected Health information. 

"Enlitic is excited to collaborate with a company like Clairvo that shares our philosophy and sense of mission" says Jim Conyers, CEO of Enlitic. "Together we are addressing issues in digital health utilizing advanced technologies like artificial intelligence. AI can address data standardization that solves issues with display protocols, routing rules, billing and coding challenges and incomplete, inaccurate or missing PHI." Enlitic’s AI radiology solutions address issues that impact clinical and operational efficiencies.

Clairvo aims to quickly commercialize the technologies and products of Enlitic and provides consistent support from regulatory application to distribution and sales. By bringing new technologies and products to the medical field, the number of diagnostic challenges that can be solved by technology will increase.

"In Japan, where the birthrate is declining and the population is aging, various medical issues are piling up. While the number of patients is increasing, there is a shortage of medical staff, and medical expenses and insurance premiums are on the rise. Isn't it time that the medical field is also required to improve productivity more than ever?" says Riichi Yamada, President of Clairvo Technologies. "Enlitic Curie enables us to bring this cutting-edge technology platform to radiology providers in Japan and improve their workflows."